BiotechBlog Guest Content

BiotechBlog Opportunities are available for informative, non-commercial messages. The submission guidelines are at http://www.biotechblog.com/spread-your-message-with-biotechblog , and you can see existing guest content at http://www.biotechblog.com/category/guest-content/ .

You can email submissions directly to me for posting. Please include a author headshot/company logo and author/company bio for the byline along with any submissions.

Other publishing opportunities are also available in the Journal of Commercial Biotechnology and in books. See the publishing opportunities page for more details

IPO on the Cheap?

Thumbnail image for IPO on the Cheap? April 18, 2011

This is a guest post by Jurgita Ashley You are a small company ready to take a leap into the public market, whether it is for growth, liquidity or to attract greater investor interest. But, oh man, those dollar figures for IPOs would make anyone’s head spin. But wait, don’t discount it yet as a [...]

Read the full article →

The Best Online Tech Schools Out There

December 15, 2010

This entry is a guest blog series from the Paul Bradford With new technological advances being made every day, biotechnology is a fast growing field of science. Biotechnologists in both the private and publicly funded sector are pioneering research in combining new technology with biology to improve medical practices and devices. Earning a degree in [...]

Read the full article →

Technology Continues to Fight Aids

December 6, 2010

This is a guest post from BiotechBlog reader Jack Lundee Technology Continues to Fight Aids In 2008, Sub-Saharan Africa was populated with over 22 million HIV+ inhabitants, and currently there are over 5 million Southern Africans infected with the virus. Worldwide, there are upwards of 40 million people infected with HIV, a very frightening number. [...]

Read the full article →

Biosimilar drugs to gain greater priority as decade progresses

June 21, 2010

This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs to gain greater priority as decade progresses The Patient Protection and Affordable Care Act will heighten the degree of competition in the field of biotech drugs, a fast growing area of drug therapy that is [...]

Read the full article →

Biotechnology Management Papers, 2010

June 17, 2010

These papers are from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: If You Build It, Will They Come? Derek Francis Profitability [...]

Read the full article →

Profitability and Orphans: The Role of Price and Incentives in Four Different Markets

June 16, 2010

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Profitability and Orphans: The Role of Price [...]

Read the full article →

If You Build It, Will They Come?

June 15, 2010

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. If You Build It, Will They Come? [...]

Read the full article →

Patent Analysis: A Tool for Making Strategic Business Decisions

June 14, 2010

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Patent Analysis: A Tool for Making Strategic [...]

Read the full article →

Guest post: Healthcare Reform Bill Presents Significant Opportunity for Life Science Companies Engaged in Innovative Research

May 17, 2010

This is a guest post from William H. Kitchens, partner at the Atlanta law firm Arnall Golden Gregory LLP. Do you have a response to Kitchens’ post? Respond in the comments section below. Buried in the recently enacted Patient Protection and Affordable Care Act of 2010 is a significant benefit for small- and mid-sized biotech, [...]

Read the full article →

Top 4 Healthcare Predictions for 2010

December 15, 2009

This is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Do you have a response to Cramer’s post? Post them in the comments section below. Multi-national pharmaceutical and medical technology companies will increase their investments in emerging markets, notably China and India, to access cost [...]

Read the full article →

← Previous Entries